undefined undefined undefined

Microvascular dysfunction in heart failure with preserved ejection fraction: prevalence and prognostic implications

Event: Heart Failure 2021

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2

Access

Like

Prevalence of microvascular dysfunction and association with clinical outcomes in heart failure with preserved ejection fraction

Event: ESC Congress 2020

Topic: Stress Cardiac Magnetic Resonance (CMR)

Session: Latest Advances in Cardiac Magnetic Resonance

Access

Like

Plasma Tenascin-C: a novel prognostic biomarker in heart failure with preserved ejection fraction

Event: Heart Failure 2019

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Rapid Fire 2 - Biomarker: present and future

Access

Like

Characterizing heart failure with preserved and reduced ejection fraction: an integrated clinical, imaging and plasma biomarker approach

Event: Heart Failure 2019

Topic: Pathophysiology

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access

Like

Relation of focal and diffuse fibrosis assessed by cardiovascular magnetic resonance imaging to clinical outcome in heart failure with preserved ejection fraction

Event: ESC Congress 2017

Topic: Pathophysiology and diagnosis

Session: Chronic heart failure (CHF)

Access

Like

Prevalence and prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction

Event: ESC Congress 2017

Topic: Prognosis

Session: Chronic heart failure (CHF)

Access

Like

Left atrial ejection fraction: a novel diagnostic and prognostic biomarker in heart failure with preserved ejection fraction, irrespective of cardiac rhythm

Event: ESC Congress 2017

Topic: Pathophysiology and diagnosis

Session: Chronic heart failure (CHF)

Access

Like

Utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction for diagnostic and prognostic evaluation

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: Rapid Fire 2 - Imaging in chronic heart failure

Access

Like

undefined undefined undefined

Contributor content

Microvascular dysfunction in heart failure with preserved ejection fraction: prevalence and prognostic implications

Prevalence of microvascular dysfunction and association with clinical outcomes in heart failure with preserved ejection fraction

Plasma Tenascin-C: a novel prognostic biomarker in heart failure with preserved ejection fraction

Characterizing heart failure with preserved and reduced ejection fraction: an integrated clinical, imaging and plasma biomarker approach

Relation of focal and diffuse fibrosis assessed by cardiovascular magnetic resonance imaging to clinical outcome in heart failure with preserved ejection fraction

Prevalence and prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction

Left atrial ejection fraction: a novel diagnostic and prognostic biomarker in heart failure with preserved ejection fraction, irrespective of cardiac rhythm

Utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction for diagnostic and prognostic evaluation

ESC 365 is supported by